HABIBIZAD NAZILA (See Remarks) sold 34.4% of their position (4.68K shares) of GLOBAL BLOOD THERAPEUTICS, INC. on the open market
Open‑market sale worth $314.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/19/2022ACC: 0000899243-22-029235
Officer· See Remarks
Since Mar 2022
-4.68K
Net shares
Net seller
$314.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.68K
Price / share
$67.19
Trade value
$314.31K
% of position
34.4%
8/18/2022
13.60K→8.92K
Total
Net shares
−4.68K
Net value
-$314.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2022 | S · Sale | −4.68K | $67.19 | $314.31K | 34.4% | 13.60K | 8.92K |
| Total | −4.68K | -$314.31K | ||||||
Derivative Transactions0
No derivative transactions reported